Europe Flow Cytometry Market Size, Share & Industry Trends Analysis Report By Application (Academic & Clinical and Diagnostic), By End User, By Technology (Cell Based and Bead Based), By Component, By Country and Growth Forecast, 2022 - 2028

Europe Flow Cytometry Market Size, Share & Industry Trends Analysis Report By Application (Academic & Clinical and Diagnostic), By End User, By Technology (Cell Based and Bead Based), By Component, By Country and Growth Forecast, 2022 - 2028

The Europe Flow Cytometry Market would witness market growth of 7.9% CAGR during the forecast period (2022-2028).

Depending on where the light is gathered relative to the laser's path, these measurements are referred to as forwarding angle scatter (FSC) and side angle scatters (SSC). All of the fluorophores connected to the cell will be excited almost simultaneously by the laser's light, resulting in fluorescence emission. The flow cytometer's electronics unit processes all of this light once it has been collected by the detector. The cell is no longer required after traveling through the questioning point, thus the fluidics system transports it to the disposal container.

If this were a cell sorter, the cell would now be transferred to a collection tube and utilized in subsequent experiments. Every fluorochrome has a wide range of fluorescence. The clash between fluorochromes can happen when more than one fluorochrome is utilized. Spectrum overlap refers to this circumstance. For instance, the light released by the fluorescein spans the same wavelength as it goes through the filter being used PE in the emission spectra for FITC and PE. By subtracting a portion of the FITC output from the PE indicators or vice versa, this spectral overlap is addressed.

The burden of cancer is rapidly surging in the region. In addition, according to the European Commission, in the European Union, 2.7 million people were given the disease diagnosis in 2020, and an additional 1.3 million people died from it. Cancer is a personal diagnosis that has significant effects on each patient, but it also has a profoundly negative impact on the lives of their family members. Currently, only 10% of the world's population lives in Europe, yet 25% of cancer cases do. By 2035, more than 24% more people in the EU will die from cancer, making it the top cause of death.

The Germany market dominated the Europe Flow Cytometry Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $494.1 million by 2028. The UK market is anticipated to grow a CAGR of 7% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 8.7% during (2022 - 2028).

Based on Application, the market is segmented into Academic & Clinical and Diagnostic. Based on End User, the market is segmented into Commercial Organizations, Hospitals, Academic Institutions, Medical Schools & Clinical Testing Labs, and Others. Based on Technology, the market is segmented into Cell Based and Bead Based. Based on Component, the market is segmented into Instruments, Reagents & Consumables, Software, and Services. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, BioMérieux S.A., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Miltenyi Biotec B.V. & Co. KG, Sartorius AG, and Sysmex Corporation.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Academic & Clinical
  • Diagnostic
By End User
  • Commercial Organizations
  • Hospitals
  • Academic Institutions
  • Medical Schools & Clinical Testing Labs
  • Others
By Technology
  • Cell Based
  • Bead Based
By Component
  • Instruments
  • Reagents & Consumables
  • Software
  • Services
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Becton Dickinson and Company
  • BioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • Miltenyi Biotec B.V. & Co. KG
  • Sartorius AG
  • Sysmex Corporation
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Flow Cytometry Market, by Application
1.4.2 Europe Flow Cytometry Market, by End User
1.4.3 Europe Flow Cytometry Market, by Technology
1.4.4 Europe Flow Cytometry Market, by Component
1.4.5 Europe Flow Cytometry Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Europe Flow Cytometry Market by Application
4.1 Europe Academic & Clinical Market by Country
4.2 Europe Diagnostic Market by Country
Chapter 5. Europe Flow Cytometry Market by End User
5.1 Europe Commercial Organizations Market by Country
5.2 Europe Hospitals Market by Country
5.3 Europe Academic Institutions Market by Country
5.4 Europe Medical Schools & Clinical Testing Labs Market by Country
5.5 Europe Other End User Market by Country
Chapter 6. Europe Flow Cytometry Market by Technology
6.1 Europe Cell Based Market by Country
6.2 Europe Bead Based Market by Country
Chapter 7. Europe Flow Cytometry Market by Component
7.1 Europe Instruments Market by Country
7.2 Europe Reagents & Consumables Market by Country
7.3 Europe Software Market by Country
7.4 Europe Services Market by Country
Chapter 8. Europe Flow Cytometry Market by Country
8.1 Germany Flow Cytometry Market
8.1.1 Germany Flow Cytometry Market by Application
8.1.2 Germany Flow Cytometry Market by End User
8.1.3 Germany Flow Cytometry Market by Technology
8.1.4 Germany Flow Cytometry Market by Component
8.2 UK Flow Cytometry Market
8.2.1 UK Flow Cytometry Market by Application
8.2.2 UK Flow Cytometry Market by End User
8.2.3 UK Flow Cytometry Market by Technology
8.2.4 UK Flow Cytometry Market by Component
8.3 France Flow Cytometry Market
8.3.1 France Flow Cytometry Market by Application
8.3.2 France Flow Cytometry Market by End User
8.3.3 France Flow Cytometry Market by Technology
8.3.4 France Flow Cytometry Market by Component
8.4 Russia Flow Cytometry Market
8.4.1 Russia Flow Cytometry Market by Application
8.4.2 Russia Flow Cytometry Market by End User
8.4.3 Russia Flow Cytometry Market by Technology
8.4.4 Russia Flow Cytometry Market by Component
8.5 Spain Flow Cytometry Market
8.5.1 Spain Flow Cytometry Market by Application
8.5.2 Spain Flow Cytometry Market by End User
8.5.3 Spain Flow Cytometry Market by Technology
8.5.4 Spain Flow Cytometry Market by Component
8.6 Italy Flow Cytometry Market
8.6.1 Italy Flow Cytometry Market by Application
8.6.2 Italy Flow Cytometry Market by End User
8.6.3 Italy Flow Cytometry Market by Technology
8.6.4 Italy Flow Cytometry Market by Component
8.7 Rest of Europe Flow Cytometry Market
8.7.1 Rest of Europe Flow Cytometry Market by Application
8.7.2 Rest of Europe Flow Cytometry Market by End User
8.7.3 Rest of Europe Flow Cytometry Market by Technology
8.7.4 Rest of Europe Flow Cytometry Market by Component
Chapter 9. Company Profiles
9.1 Becton, Dickinson and Company
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.1.5.3 Approvals and Trials:
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Acquisition and Mergers:
9.3 Danaher Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.4 Agilent Technologies, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.4.5.2 Acquisition and Mergers:
9.5 BioMérieux S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.6 Bio-Rad laboratories, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.7 DiaSorin S.p.A.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expenses
9.8 Miltenyi Biotech B.V. & Co. KG
9.8.1 Company Overview
9.9 Sartorius AG
9.9.1 Company Overview
9.10. Sysmex Corporation
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Product Launches and Product Expansions:

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings